RxDoctor Payments Data

Taryn Ostrom, NP

Family · Shelby Township, MINPI 1083202923

Payments from drug & device makers

$443in general payments, 2019–2025

Across 23 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$123
  • Exact Sciences$102
  • Novo Nordisk$65
  • Lilly USA, LLC$49
  • GSK$35
  • Boston Scientific$29
  • plus $41 from 2 others

What the payments were for

  • Food & beverage$443100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$443 in reported general payments places this provider in the 50th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$48,964
Medicare patients
192
Services billed
830

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$48,316
JardianceEmpagliflozin21$30,699
XareltoRivaroxaban21$26,693
RybelsusSemaglutide13$26,287
JanuviaSitagliptin Phosphate20$25,545
OzempicSemaglutide14$20,351
MounjaroTirzepatide12$17,755
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$17,301
Breo ElliptaFluticasone/Vilanterol20$9,912
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$5,369
Atorvastatin Calcium328$4,526
Levothyroxine Sodium219$3,113
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$3,077
Metoprolol Succinate127$2,951
Lisinopril287$2,799

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$65$46,63827 claims
Boehringer IngelheimJardiance$23$30,69921 claims
GSKTrelegy Ellipta, Breo Ellipta$35$27,21333 claims
Lilly USA, LLCMounjaro$49$17,75512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,657 family providers in Michigan.

Other family in Shelby Township

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →